JPH01279816A - Body rinse composition - Google Patents
Body rinse compositionInfo
- Publication number
- JPH01279816A JPH01279816A JP10694388A JP10694388A JPH01279816A JP H01279816 A JPH01279816 A JP H01279816A JP 10694388 A JP10694388 A JP 10694388A JP 10694388 A JP10694388 A JP 10694388A JP H01279816 A JPH01279816 A JP H01279816A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- oil
- acid
- composition
- polysiloxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- -1 polysiloxane Polymers 0.000 claims abstract description 56
- 239000003921 oil Substances 0.000 claims abstract description 31
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 23
- 239000010696 ester oil Substances 0.000 claims abstract description 13
- 238000003287 bathing Methods 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 abstract description 7
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 abstract description 6
- 229940088594 vitamin Drugs 0.000 abstract description 4
- 229930003231 vitamin Natural products 0.000 abstract description 4
- 239000011782 vitamin Substances 0.000 abstract description 4
- 235000013343 vitamin Nutrition 0.000 abstract description 4
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- 239000005556 hormone Substances 0.000 abstract description 3
- 239000002562 thickening agent Substances 0.000 abstract description 3
- 206010040880 Skin irritation Diseases 0.000 abstract description 2
- 239000003906 humectant Substances 0.000 abstract description 2
- 230000036556 skin irritation Effects 0.000 abstract description 2
- 231100000475 skin irritation Toxicity 0.000 abstract description 2
- 239000002304 perfume Substances 0.000 abstract 1
- 230000036620 skin dryness Effects 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 description 28
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 11
- 239000008213 purified water Substances 0.000 description 11
- 206010013786 Dry skin Diseases 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 10
- 230000037336 dry skin Effects 0.000 description 10
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 10
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 239000006071 cream Substances 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 9
- 230000036555 skin type Effects 0.000 description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 8
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 8
- 229960002216 methylparaben Drugs 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- 239000004166 Lanolin Substances 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 206010039792 Seborrhoea Diseases 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 235000019388 lanolin Nutrition 0.000 description 6
- 229940039717 lanolin Drugs 0.000 description 6
- 230000037312 oily skin Effects 0.000 description 6
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 6
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 6
- 229960003415 propylparaben Drugs 0.000 description 6
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 229960000458 allantoin Drugs 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 4
- 244000184734 Pyrus japonica Species 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 4
- 239000001587 sorbitan monostearate Substances 0.000 description 4
- 229940035048 sorbitan monostearate Drugs 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229960004756 ethanol Drugs 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 2
- 241000157282 Aesculus Species 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 235000015655 Crocus sativus Nutrition 0.000 description 2
- 244000124209 Crocus sativus Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 241001125048 Sardina Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 238000004847 absorption spectroscopy Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000010639 cypress oil Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 229960002350 guaiazulen Drugs 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000010181 horse chestnut Nutrition 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940105132 myristate Drugs 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- 235000019719 rose oil Nutrition 0.000 description 2
- 235000013974 saffron Nutrition 0.000 description 2
- 239000004248 saffron Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- BXOCHUWSGYYSFW-HVWOQQCMSA-N spilanthol Chemical compound C\C=C\C=C/CC\C=C\C(=O)NCC(C)C BXOCHUWSGYYSFW-HVWOQQCMSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000003357 wound healing promoting agent Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- FBZQBGYPONNWCG-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone Chemical compound COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC FBZQBGYPONNWCG-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- GCKMFJBGXUYNAG-UHFFFAOYSA-N 17alpha-methyltestosterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C)(O)C1(C)CC2 GCKMFJBGXUYNAG-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 1
- GXJQMKFJQFGQKV-KHPPLWFESA-N 2-[methyl-[(z)-octadec-9-enoyl]amino]ethanesulfonic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CCS(O)(=O)=O GXJQMKFJQFGQKV-KHPPLWFESA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N 2-methylnonane Chemical compound CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- PUYOAVGNCWPANW-UHFFFAOYSA-N 2-methylpropyl 4-aminobenzoate Chemical compound CC(C)COC(=O)C1=CC=C(N)C=C1 PUYOAVGNCWPANW-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- PBBGSZCBWVPOOL-HDICACEKSA-N 4-[(1r,2s)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol Chemical compound C1([C@H](CC)[C@H](CC)C=2C=CC(O)=CC=2)=CC=C(O)C=C1 PBBGSZCBWVPOOL-HDICACEKSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- DBOSBRHMHBENLP-UHFFFAOYSA-N 4-tert-Butylphenyl Salicylate Chemical compound C1=CC(C(C)(C)C)=CC=C1OC(=O)C1=CC=CC=C1O DBOSBRHMHBENLP-UHFFFAOYSA-N 0.000 description 1
- ZUGAOYSWHHGDJY-UHFFFAOYSA-K 5-hydroxy-2,8,9-trioxa-1-aluminabicyclo[3.3.2]decane-3,7,10-trione Chemical compound [Al+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZUGAOYSWHHGDJY-UHFFFAOYSA-K 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 244000075898 Lantana strigocamara Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- HDVDLQFPDLTOSI-UHFFFAOYSA-L O[AlH]O Chemical compound O[AlH]O HDVDLQFPDLTOSI-UHFFFAOYSA-L 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241001271990 Tomicus piniperda Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- BXOCHUWSGYYSFW-UHFFFAOYSA-N all-trans spilanthol Natural products CC=CC=CCCC=CC(=O)NCC(C)C BXOCHUWSGYYSFW-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- GCVCIVDNHNBFMS-UHFFFAOYSA-K aluminum;benzenesulfonic acid;trihydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3].OS(=O)(=O)C1=CC=CC=C1.OS(=O)(=O)C1=CC=CC=C1.OS(=O)(=O)C1=CC=CC=C1 GCVCIVDNHNBFMS-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BJFLSHMHTPAZHO-UHFFFAOYSA-N benzotriazole Chemical compound [CH]1C=CC=C2N=NN=C21 BJFLSHMHTPAZHO-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 239000001518 benzyl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- NGHOLYJTSCBCGC-QXMHVHEDSA-N benzyl cinnamate Chemical compound C=1C=CC=CC=1\C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-QXMHVHEDSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 239000010629 calamus oil Substances 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- SFHUSLFRIKHKPE-UHFFFAOYSA-L chloro-[(2,5-dioxoimidazolidin-4-yl)carbamoylamino]aluminum;hydrate Chemical compound O.NC(=O)NC1NC(=O)N([Al]Cl)C1=O SFHUSLFRIKHKPE-UHFFFAOYSA-L 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- NGHOLYJTSCBCGC-UHFFFAOYSA-N cis-cinnamic acid benzyl ester Natural products C=1C=CC=CC=1C=CC(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- RHPIJWYTYJJCFU-UHFFFAOYSA-L diacetyloxyaluminum;hydrate Chemical compound O.CC(=O)O[Al]OC(C)=O RHPIJWYTYJJCFU-UHFFFAOYSA-L 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229960004960 dioxybenzone Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 229950001996 hexestrol Drugs 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960004011 methenamine Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229950002083 octabenzone Drugs 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- RCMHUQGSSVZPDG-UHFFFAOYSA-N phenoxybenzene;phosphoric acid Chemical compound OP(O)(O)=O.C=1C=CC=CC=1OC1=CC=CC=C1 RCMHUQGSSVZPDG-UHFFFAOYSA-N 0.000 description 1
- FURYAADUZGZUGQ-UHFFFAOYSA-N phenoxybenzene;sulfuric acid Chemical class OS(O)(=O)=O.C=1C=CC=CC=1OC1=CC=CC=C1 FURYAADUZGZUGQ-UHFFFAOYSA-N 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229940010310 propylene glycol dioleate Drugs 0.000 description 1
- 229950008679 protamine sulfate Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 235000019385 spermaceti wax Nutrition 0.000 description 1
- 239000010675 spruce oil Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical group 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、使用者が肌の状態(がさつく、油っぽい)や
肌の適用部位を考慮せず、また、季節を考慮せずに全身
にすぐれたボディケア効果を得ることができる新規なボ
ディリンス組成物に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention allows the user to use the product without considering the condition of the skin (rough, oily) or the application area of the skin, or without considering the season. This invention relates to a novel body rinse composition that can provide excellent body care effects to the whole body.
一般に女性は、風呂を上がると身体についた水気をふき
とった後、ヒジ、ヒザを中心とした肌のカサつきや肌荒
れを感じた部位の手入れのためにクリームや乳液などの
化粧料を使用している。Generally, after getting out of the bath and wiping off the water on their bodies, women use cosmetics such as creams and milky lotions to care for areas where they feel dry or rough, especially around the elbows and knees. There is.
このようなボディーの特定部位に対するクリームや乳液
化粧料の適用は、風呂上がりに意識しないとすぐに忘れ
るもので、後で気づいて適用しようとしても、その適用
は非常に面倒である。また、このような化粧料は、実際
に必要性を感じた部位のみに適用される傾向があり、カ
サつきや肌荒れを生じやすい他の予備群的部位に対する
適用は忘れられやすい。Application of cream or milky lotion cosmetics to specific parts of the body is easily forgotten unless one is conscious of it after taking a bath, and even if one notices it later and tries to apply it, it is very troublesome to apply. Moreover, such cosmetics tend to be applied only to areas where it is actually felt necessary, and application to other areas prone to dryness or rough skin is easily forgotten.
さらに、前記乳液やクリーム化粧料は、肌のカサつきや
肌荒れを生じてない部位に適用すると。Furthermore, when the emulsion or cream cosmetic is applied to areas where the skin is not dry or rough.
逆にベタつきを生じるため、全身ボディケア製品として
は不適当のものである。On the contrary, it causes stickiness, making it unsuitable as a whole body care product.
一方、現在のところ、簡単かつ無意識的に適用しても、
前記の如き肌のカサつきや肌荒れの部位はもちろん、肌
のカサつきや肌荒れの生じやすい予備群的部へも同時に
適用され、肌のカサつきや肌荒れの解消及び予防に効果
のある全身ボディケア効果を有する製品は存在しない。On the other hand, at present, even when applied easily and unconsciously,
Full-body body care that is effective in eliminating and preventing dry skin and rough skin, as it can be applied not only to areas with dry skin and rough skin as mentioned above, but also to areas prone to dry skin and rough skin. There are no products that are effective.
−船釣に、女性の肌は、例えば、ヒジ、ヒザ等ではカサ
つくが、反対に、背中等では油っぽく、べたつきがちで
あり、肌の部位によりその状態が異なる。従って、−本
の製品での全身ボディケアは望めず、肌の状態、季節等
により使用する製品を変えなければならないために非常
に面倒であり、また−本の製品で望ましい肌の状態を保
持することは非常に困難である。その理由としては、た
だ単に、基礎化粧品として知られているクリームや乳液
をボディリンスとして使用しても、軽くすすぎ流す段階
で乳化剤と共に、はとんどの成分が流し落とされてしま
うため、ボディリンスに要求される、肌をすべすべにす
る、しっとりさせる等の使用効果が発現されないことに
よる。- When fishing on a boat, women's skin tends to be dry on the elbows and knees, but on the other hand, on the back, etc., it tends to be oily and sticky, and the condition differs depending on the skin area. Therefore, - you cannot expect to take care of your whole body with this product, and it is very troublesome as you have to change the products you use depending on your skin condition, season, etc., and - you cannot maintain the desired skin condition with this product. It is very difficult to do so. The reason for this is simply that even if you use creams and emulsions known as basic cosmetics as a body rinse, most of the ingredients will be washed away along with the emulsifier during the light rinsing stage. This is because the desired effects of use, such as making the skin smooth and moisturized, are not achieved.
また、毛髪化粧料に用いられているヘアリンスをボディ
リンスに応用することも考えられないわけではないが、
ヘアリンスをそのままボディリンスに使用した場合には
、過度のぬるつきが生じる上、ヘアリンスに一般に含ま
れているカチオン界面活性剤は、他の界面活性剤に比較
し、皮膚刺激が強いという難点があり、好ましいもので
はない。Also, it is not inconceivable that hair rinses used in hair cosmetics could be applied to body rinses.
If a hair rinse is used as a body rinse, it will leave an excessively slimy feel, and the cationic surfactants commonly contained in hair rinses have the disadvantage of being more irritating to the skin than other surfactants. , not desirable.
そのほかに、入浴剤として、スキンケア効果をうたうも
のがあるが、これら入浴剤においては、肌に所望の油分
が付着しにくい等のため、高度なボディケア効果は得ら
れない。In addition, there are bath additives that claim to have skin care effects, but these bath additives do not have high body care effects because desired oils are difficult to adhere to the skin.
したがって、現状においては、−本の製品で肌荒れに効
果を有するとともに、肌のカサついたり、乾燥しがちな
部位には、しっとり感を与え、その上、肌の油っぽく、
べたつきやすい部位には、肌をさっばりさせ、すべすべ
にさせる効果を兼ね備えた使用者の要望を満足しうる組
成物は得られていない。Therefore, at present, this product is effective against rough skin, provides a moisturizing effect on areas of the skin that tend to become dry or dry, and also reduces oily skin.
For areas that are prone to stickiness, no composition has been obtained that satisfies the user's needs and has the effect of making the skin light and smooth.
本発明は、従来市場において殆ど知られていない、無意
識的に適用しても、前記肌のカサつきや肌荒れの解消及
び予備効果を示す新規なボディケア製品を提供すること
を目的とする。さらに詳しくは1本発明は、肌荒れに効
果を有するとともに、肌のカサつき及び乾燥しがちな部
位には、しっとり感、すべすべ感を与え、また、反対に
、肌の油っぽく、ベタつきやすい部位には、さっばり感
、すべすべ感を与える全身ボディケア効果にすぐれたボ
ディリンス組成物を提供することを目的とする。An object of the present invention is to provide a novel body care product, which has been almost unknown in the conventional market, and which exhibits a preliminary effect and eliminates dry skin and rough skin even when applied unconsciously. More specifically, 1. The present invention is effective against rough skin, provides a moist and smooth feeling to areas of the skin that are prone to dryness and dryness, and, on the contrary, provides oily and sticky areas of the skin. The purpose of the present invention is to provide a body rinse composition with excellent whole body care effects that gives a refreshing and smooth feeling.
本発明者らは、前記問題点を解決すべく鋭意研究を重ね
た結果、製品のタイプをすすぎ流すタイプの乳化剤組成
物とし、かつ、不揮発性ポリシロキサンとエステル油を
組み合せて用いることにより、前記問題点を解決し得る
使用感の良好なボディリンス組成物が得られることを見
い出し、本発明を完成するに至った。As a result of intensive research to solve the above-mentioned problems, the present inventors have developed a rinse-off type emulsifier composition for the product, and by using a combination of non-volatile polysiloxane and ester oil, the above-mentioned problems have been solved. The present inventors have discovered that a body rinse composition that can solve the problems and has a good feeling of use can be obtained, and have completed the present invention.
すなわち、本発明によれば、組成物全体に対する油分量
が2〜50重量%である乳化物であって、不揮発性ポリ
シロキサンを1〜40重量%含有し、かつ、エステル油
を1〜40重量X含有することを特徴とする入浴後の肌
に塗布し、軽くすすぎ流して使用するボディリンス組成
物が提供される。That is, according to the present invention, the emulsion has an oil content of 2 to 50% by weight based on the entire composition, contains 1 to 40% by weight of nonvolatile polysiloxane, and contains 1 to 40% by weight of ester oil. Provided is a body rinse composition that is characterized by containing X and is used by applying it to the skin after bathing and rinsing it off.
本発明に用いられる油分は、不揮発性ポリシロキサンと
エステル油を含むものである。必要に応じて他の油分を
添加することができる。The oil component used in the present invention contains nonvolatile polysiloxane and ester oil. Other oils can be added as needed.
本発明の組成物における油分量は、2〜50重量%の範
囲に規定するのが好ましい、2重量%より少ないと、肌
をすべすべにする、しっとりさせる等のボディケア効果
に乏しく、50重量2を超えると、べたつきが生じたり
、組成物の乳化安定性が劣化する等の問題点が生じる。The amount of oil in the composition of the present invention is preferably defined in the range of 2 to 50% by weight; if it is less than 2% by weight, body care effects such as making the skin smooth and moisturized will be poor; If it exceeds this amount, problems such as stickiness and deterioration of the emulsion stability of the composition occur.
より好ましい油分量は、3〜40重量%である。A more preferable oil content is 3 to 40% by weight.
不揮発性ポリシロキサンとしては、例えば粘度10〜1
00000センチストークスのメチルポリシロキサン、
メチルフェニルポリシロキサン、及び/又はジメチルト
リメチルポリシロキサンが好ましい。For example, the nonvolatile polysiloxane has a viscosity of 10 to 1
00000 centistokes methylpolysiloxane,
Methylphenylpolysiloxane and/or dimethyltrimethylpolysiloxane are preferred.
その使用量は、1〜40重量%である。1重量%より少
なくなると、肌がすべすべしなくなるだけでなく、しっ
とりさせる効果も充分でない、又40重量%を超えると
、ポリシロキサンが乳化されにくくなる。The amount used is 1 to 40% by weight. If it is less than 1% by weight, not only will the skin not be smooth, but it will not have a sufficient moisturizing effect, and if it exceeds 40% by weight, it will be difficult to emulsify the polysiloxane.
より好ましいポリシロキサンの使用量は2〜40重量%
である。The more preferable amount of polysiloxane used is 2 to 40% by weight.
It is.
エステル油としては、常温で液状もしくはペースト状を
呈するものであり1例えば、ミリスチン酸イソプロピル
、パルミチン酸イソプロピル、ステアリン酸ブチル、ラ
ウリン酸ヘキシル、オレイン酸オレイル、オレイン酸デ
シル、ミリスチン酸オクチルデシル、ジメチルオクタン
酸へキシルデシル、乳酸セチル、乳酸ミリスチル、フタ
ル酸ジエチル、フタル酸ジブチル、酢酸ラノリン、ジオ
レイン酸プロピレングリコール等が好ましい、エステル
油の使用量は、1−400重量%ある。1重量%より少
なくなると、カサついたり、肌荒れしている部位のしっ
とり感が充分でない、又、400重量%超えると、油っ
ぽく、べたつきやすい部位での油っぽさやべたつきが強
くなり、合わせてすべすべ感も悪くなる。より好ましい
エステル油の使用量は2〜40重量算である。Ester oils are liquid or paste-like at room temperature. Examples include isopropyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, oleyl oleate, decyl oleate, octyldecyl myristate, and dimethyl octane. Hexyldecyl acid, cetyl lactate, myristyl lactate, diethyl phthalate, dibutyl phthalate, lanolin acetate, propylene glycol dioleate, etc. are preferred, and the amount of ester oil used is 1-400% by weight. If it is less than 1% by weight, areas with dry or rough skin will not feel moisturized enough, and if it exceeds 400% by weight, areas that tend to be oily or sticky will become oily and sticky. The feeling of slippery skin also worsens. A more preferable amount of ester oil to be used is 2 to 40% by weight.
なお、油分を構成する不揮発性油分としては、前記不揮
発性ポリシロキサンの他に、必要に応じ。In addition to the non-volatile polysiloxane, the non-volatile oil component constituting the oil component may include, if necessary, in addition to the non-volatile polysiloxane.
他の不揮発性油分を用いることができる。Other fixed oils can be used.
このような油分としては、例えば、オリーブ油。An example of such oil is olive oil.
アルモンド油、ゴマ油、サフラワー油、大豆油、ツバキ
油、バーシック油、ヒマシ油、綿実油、ミンク油、カカ
オ脂、モクロウ、ヤシ油等の油脂類;ミツロウ、カルナ
ウバロウ、鯨ロウ、ラノリン、液状ラノリン、カンデリ
ラロウ等のロウ類;流動パラフィン、ワセリン、パラフ
ィン、セレシン。Fats and oils such as almond oil, sesame oil, safflower oil, soybean oil, camellia oil, versic oil, castor oil, cottonseed oil, mink oil, cacao butter, Japanese wax, and coconut oil; beeswax, carnauba wax, spermaceti wax, lanolin, liquid lanolin, Waxes such as candelilla wax; liquid paraffin, petrolatum, paraffin, ceresin.
マイクロクリスタリンワックス、スクワラン等の炭化水
素;ラウリン酸、ミリスチン酸、パルミチン酸、ステア
リン酸、ベヘニン酸、オレイン酸、12〜ヒドロキシス
テアリン酸、ウンデシレン酸、ラノリン脂肪酸、イソス
テアリン酸等の高級脂肪酸;ラウリルアルコール、セタ
ノール、ステアリルアルコール、オレイルアルコール、
ラノリンアルコール、コレステロール、フィトステロー
ル。Hydrocarbons such as microcrystalline wax and squalane; Higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, 12-hydroxystearic acid, undecylenic acid, lanolin fatty acid, and isostearic acid; lauryl alcohol, Setanol, stearyl alcohol, oleyl alcohol,
Lanolin alcohol, cholesterol, phytosterols.
2〜へキシルデカノール、イソステアリルアルコール、
2〜オクチルドデカノール等の高級アルコール等が挙げ
られる。2~hexyldecanol, isostearyl alcohol,
Higher alcohols such as 2-octyldodecanol and the like can be mentioned.
本発明のボディリンス組成物を乳化物とするためには、
通常、乳化剤として作用するアニオン界面活性剤、ノニ
オン界面活性剤、カチオン界面活性剤、両性イオン界面
活性剤を所望に応じて添加することができる。In order to make the body rinse composition of the present invention into an emulsion,
Usually, anionic surfactants, nonionic surfactants, cationic surfactants, and amphoteric ionic surfactants that act as emulsifiers can be added as desired.
アニオン界面活性剤としては、例えば、脂肪酸塩(石け
ん類)、アルキルベンゼンスルホン酸塩。Examples of anionic surfactants include fatty acid salts (soaps) and alkylbenzene sulfonates.
アルキルナフタレンスルホン酸塩、アルキルスルホン酸
塩、α−オレフシンスルホン酸塩、ジアルキルスルフオ
こはく酸塩、α−スルフォン化脂肪酸塩、ナトリウムN
−メチル−N−オレオイルタウリン、石油スルフォン酸
塩、アルキル硫酸塩、硫酸化油脂、ポリオキシエチレン
スチレン化フェニルエーテル硫酸塩、アルキルリン酸塩
、ポリオキシエチレンアルキルエーテルリン酸塩、ポリ
オキシエチレンアルキルフェニルエーテルリン酸塩、ナ
フタレンスルホン酸塩ホルマリン縮合物等が挙げられる
。Alkylnaphthalene sulfonate, alkyl sulfonate, α-olefusin sulfonate, dialkyl sulfosuccinate, α-sulfonated fatty acid salt, sodium N
-Methyl-N-oleoyl taurine, petroleum sulfonate, alkyl sulfate, sulfated fat, polyoxyethylene styrenated phenyl ether sulfate, alkyl phosphate, polyoxyethylene alkyl ether phosphate, polyoxyethylene alkyl Examples include phenyl ether phosphate, naphthalene sulfonate formalin condensate, and the like.
ノニオン界面活性剤としては1例えば、ポリオキシエチ
レンアルキルエーテル、ポリオキシエチレンアルキルフ
ェニルエーテル、ポリオキシエチレンポリスチリルフェ
ニルエーテル、ポリオキシエチレンポリオキシブロビレ
ングリコール、多価アルコール脂肪酸部分エステル、ポ
リオキシエチレン多価アルコール脂肪酸部分エステル、
ポリオキシエチレン脂肪酸エステル、ポリグリセリン脂
肪酸エステル、ポリオキシエチレン硬化ひまし油、ポリ
オキシエチレンアルキルアミン、トリエタノールアミン
脂肪酸部分エステル、トリアルキルアミンオキサイド等
が挙げられる。Examples of nonionic surfactants include polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene polystyrylphenyl ether, polyoxyethylene polyoxybrobylene glycol, polyhydric alcohol fatty acid partial ester, polyoxyethylene polyester, etc. Hydrolic alcohol fatty acid partial ester,
Examples include polyoxyethylene fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkylamine, triethanolamine fatty acid partial ester, and trialkylamine oxide.
両性イオン界面活性剤としては、例えば、N、N−ジメ
チル−N−アルキル−N−カルボキシメチルアンモニウ
ムベタイン、N、N−ジアルキルアミノアルキレンカル
ボン酸、N、N、N−トリアルキル−N−スルフォアル
キレンアンモニウムベタイン、N、N−ジアルキル−N
、N−ビスポリオキシエチレンアンモニウム硫酸エステ
ルベタイン、2〜アルキル−1−ヒドロキシ−1−力ル
ボキシメチルイミダゾリニウムベタイン等が挙げられる
。Examples of the zwitterionic surfactant include N,N-dimethyl-N-alkyl-N-carboxymethylammonium betaine, N,N-dialkylaminoalkylenecarboxylic acid, and N,N,N-trialkyl-N-sulfonate. Alkylene ammonium betaine, N,N-dialkyl-N
, N-bispolyoxyethylene ammonium sulfate betaine, 2-alkyl-1-hydroxy-1-hydroxymethylimidazolinium betaine, and the like.
カチオン界面活性剤としては、第1級〜第3級脂肪酸ア
ミン塩、テトラアルキルアンモニウム塩。Examples of cationic surfactants include primary to tertiary fatty acid amine salts and tetraalkylammonium salts.
トリアルキルベンジルアンモニウム塩、アルキルピリジ
ニウム塩、2〜アルキル−1−アルキル−1−ヒドロキ
シエチルイミダゾリニウム塩、N、N−ジアルキルモル
フオリニウム塩、ポリエチレンポリアミン脂肪酸アミド
塩、ポリエチレンポリアミン脂肪酸アミドの尿素締金物
の第4級アンモニウム塩等が挙げられる。Trialkylbenzylammonium salts, alkylpyridinium salts, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salts, N,N-dialkylmorpholinium salts, polyethylene polyamine fatty acid amide salts, urea binding of polyethylene polyamine fatty acid amide Examples include quaternary ammonium salts of hardware.
本発明の乳化組成物は、従来知られた乳化方法により調
製することができる。一般に、化粧料では乳化剤量の割
合は、乳化安定性等の点から油分量に対して20〜30
重量%用いられるが、本発明のボディリンス組成物にお
いては、界面活性剤が少ない程油分の吸着量が増加する
ことから安定性を確保出来る範囲で界面活性剤を減らす
ことができる。The emulsified composition of the present invention can be prepared by a conventionally known emulsification method. Generally, in cosmetics, the ratio of emulsifier to oil content is 20 to 30% from the viewpoint of emulsion stability.
In the body rinse composition of the present invention, the amount of oil adsorbed increases as the amount of surfactant decreases, so the amount of surfactant can be reduced within a range that ensures stability.
好ましい界面活性剤の使用量は油分量に対して20重量
%以下である。The preferred amount of surfactant used is 20% by weight or less based on the amount of oil.
本発明組成物には、前記必須成分の他、所望に応じて、
揮発性ポリシロキサン、生薬、増粘剤、ビタミン類、ア
ミノ酸類、ホルモン類、保湿剤。In addition to the above-mentioned essential components, the composition of the present invention may optionally contain:
Volatile polysiloxane, herbal medicines, thickeners, vitamins, amino acids, hormones, humectants.
紫外線吸収剤、防腐剤、殺菌剤、抗炎症剤、創傷治癒剤
、精油類、収れん剤、発汗防止防臭剤、香料、色素等を
添加することができる。Ultraviolet absorbers, preservatives, bactericidal agents, anti-inflammatory agents, wound healing agents, essential oils, astringents, antiperspirants, deodorants, fragrances, pigments, etc. can be added.
前記揮発性ポリシロキサンとしては、例えば、ヘキサメ
チルシクロトリシロキサン、オクタメチルシクロテトラ
シロキサン、デカメチルシクロペンタシロキサン、粘度
2センチストークス以下の低粘度鎖状メチルポリシロキ
サン等をあげることができる。Examples of the volatile polysiloxane include hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and low-viscosity linear methylpolysiloxane having a viscosity of 2 centistokes or less.
前記生薬としては、例えば、ソウジュラ、ビヤクジュツ
、カノコソウ、ケイガイ、コウボク、センキュウ、トウ
ヒ、トウキ、ショウキョウ、オウゴン、サンシン、ガイ
ヨウ、アロエ、ニンジン。Examples of the herbal medicines include sourdough, valerian, japonica, kobo, nebula, spruce, japonica, ginger, scutellariae, scutellariae, staghorn, aloe, and ginseng.
ケイヒ、シャクヤク、ハツカ葉、オウゴン、ブクリヨウ
、ショウブ、マツブサ、ビヤクシ、サフラン、オウバク
、ウィキョウ、チンピ、カンピ、カミツレ、ダイコン、
ヤナギ、クスノキ、ニワトコ、ソクズ、ナキナタコウジ
ュ、ヤツデ、セキショウ、ヨモギ、オトギリソウ、ユズ
、ダイダイ、モモ。Keihi, peony, honeysuckle leaf, scutellariae, scutellariae, calamus, pine beetle, beetroot, saffron, saffron, fenugreek, chimpi, campi, chamomile, radish,
Willow, camphor tree, elderberry, Japanese sardine, Japanese sardine, Japanese japanese japonica, red herring, mugwort, hypericum, yuzu, Japanese daidai, and peach.
サイカチ、ビワ、スイカズラ、ヨロイグサ、ボダイジュ
、トチツキ、ノコギリソウ、ホップ、ローズマリー、カ
バツキ、マツ、ヤレンズラ、ランタナ、カンゾウ、キラ
ソウコン、マロニエ等がある。There are cypress, loquat, honeysuckle, Japanese weed, Japanese daisy, horse chestnut, yarrow, hop, rosemary, birch, pine, japonica, lantana, daylily, turmeric, horse chestnut, etc.
これらはその粉末でも抽出エキスであってもよい。These may be powders or extracts thereof.
また、増粘剤としては、例えば、カゼイン、カルボキシ
メチルセルロースナトリウム、水溶性ゼラチン、ペクチ
ン、デンプン、メチルセルロース、エチルセルロース、
アルギン酸ナトリウム、ポリビニルアルコール、°ポリ
ビニルピロリドン、ポリビニルメチルエーテル、ポリエ
チレングリコール、カラヤゴム、ローカストビーンガム
、トラカントガム、カラギナン、カーボポール、アカシ
ャガム、カンテン等がある。Examples of thickeners include casein, sodium carboxymethylcellulose, water-soluble gelatin, pectin, starch, methylcellulose, ethylcellulose,
Examples include sodium alginate, polyvinyl alcohol, polyvinylpyrrolidone, polyvinyl methyl ether, polyethylene glycol, karaya gum, locust bean gum, tracanth gum, carrageenan, carbopol, acacia gum, agar, etc.
ビタミン類としては、例えば、ビタミンA、ビタミンB
、ビタミンC、ビタミンD、ビタミンE、ビタミンF、
ビタミンK、ビタミンP、ビタミンU、カルニチン、フ
ェルラ酸、γ−オリザノール、α−リボ酸、オロット酸
及びその誘導体等がある。Examples of vitamins include vitamin A, vitamin B
, vitamin C, vitamin D, vitamin E, vitamin F,
Examples include vitamin K, vitamin P, vitamin U, carnitine, ferulic acid, γ-oryzanol, α-riboic acid, orotic acid and derivatives thereof.
アミノ酸類としては、例えば、グリシン、アラニン、バ
リン、ロイシン、イソロイシン、セリン、トレオニン、
フェニルアラニン、チロシン、トリプトファン、シスチ
ン、システィン、メチオニン、プロリン、ヒドロキシプ
ロリン、アスパラギン酸、グルタミン酸、アルギニン、
ヒスチジン、リジン及びその誘導体等がある。Examples of amino acids include glycine, alanine, valine, leucine, isoleucine, serine, threonine,
Phenylalanine, tyrosine, tryptophan, cystine, cysteine, methionine, proline, hydroxyproline, aspartic acid, glutamic acid, arginine,
Examples include histidine, lysine and derivatives thereof.
ホルモン類としては、例えば、17−メチルテストステ
ロン、エストロン、β−エストラジオール、エチニルエ
ストラジオール、ジエチルスチルベストロール、ヘキセ
ストロール、プロゲステロン、ヒドロコルチゾン、プレ
ドニゾン、プレドニゾロン、デキサメサゾン、ベタメサ
ゾン、フルオシノロンアセトニド等を挙げることができ
る。Examples of hormones include 17-methyltestosterone, estrone, β-estradiol, ethinylestradiol, diethylstilbestrol, hexestrol, progesterone, hydrocortisone, prednisone, prednisolone, dexamethasone, betamethasone, fluocinolone acetonide, and the like. be able to.
保湿剤としては、例えば、ペプチド、ポリアミノ酸、コ
ラーゲン加水分解物及びその誘導体、ヒアルロン酸等の
ムコ多糖類、核酸やエラスチン等の蛋白質及びその誘導
体、ピロリドンカルボン酸ナトリウム、プロピレングリ
コール、エチレングリコール、ジエチレングリコール、
トリエチレングリコール、ポリエチレングリコール、ジ
プロピレングリコール、ポリプロピレングリコール、グ
リセリン、ソルビトール、ブチルアルコール、ペンタエ
リスリトール等を挙げることができる。Examples of moisturizing agents include peptides, polyamino acids, collagen hydrolysates and derivatives thereof, mucopolysaccharides such as hyaluronic acid, proteins such as nucleic acids and elastin and derivatives thereof, sodium pyrrolidone carboxylate, propylene glycol, ethylene glycol, and diethylene glycol. ,
Examples include triethylene glycol, polyethylene glycol, dipropylene glycol, polypropylene glycol, glycerin, sorbitol, butyl alcohol, and pentaerythritol.
紫外線吸収剤としては、例えば、p−アミノ安息香酸、
p−アミノ安息香酸エチル、p−アミノ安息香酸イソブ
チル、p−アミノ安息香酸グリセリル、 p−ジメチル
アミノ安息香酸アミル、サリチル酸エチレングリコール
、サリチル酸フェニル、サリチル酸p−tert−ブチ
ルフェニル、サリチル酸ベンジル、アントラニル酸メン
チル、ウンベリフェロン、エスクリン、ケイ皮酸ベンジ
ル、シノキサート、グアイアズレン、ウロカニン酸、2
〜(2〜ヒドロキシ−1−メチルフェニル)ベンゾトリ
アゾール、オキシベンゾン、ジオキシベンゾン、オクタ
ベンゾン。Examples of ultraviolet absorbers include p-aminobenzoic acid,
Ethyl p-aminobenzoate, isobutyl p-aminobenzoate, glyceryl p-aminobenzoate, amyl p-dimethylaminobenzoate, ethylene glycol salicylate, phenyl salicylate, p-tert-butylphenyl salicylate, benzyl salicylate, menthyl anthranilate , umbelliferone, esculin, benzyl cinnamate, cinoxate, guaiazulene, urocanic acid, 2
~(2-hydroxy-1-methylphenyl)benzotriazole, oxybenzone, dioxybenzone, octabenzone.
ジヒジロキシジメトキシベンゾフエノン、スリソベンゾ
ン、ペンゾレソルシノール、ブチルメトキシベンゾイル
メタン、オクチルメトキシシンナメート等を挙げること
ができる。Examples include dihydroxydimethoxybenzophenone, slisobenzone, penzoresorcinol, butylmethoxybenzoylmethane, octylmethoxycinnamate, and the like.
防腐剤、殺菌剤としては、例えば、クロラミンT、ソル
ビン酸、サリチル酸、デヒドロ酢酸、バラヒドロキシ安
息香酸エステル、ウロカニン酸、フェノール、クレゾー
ル、p−クロロフェノール、ベンジルアルコール
p−クロロ1−クレゾール、チモール、フェネチルアル
コール、0−フェニルフェノール、イルガサンC113
565.ハロカルパン、ヘキサクロロフェン、クロルヘ
キシジン、エチルアルコール、イソプロピルアルコール
、クロロブタノール、ヘキサミン、アクリノール等を挙
げることができる。Examples of preservatives and bactericidal agents include chloramine T, sorbic acid, salicylic acid, dehydroacetic acid, parahydroxybenzoic acid ester, urocanic acid, phenol, cresol, p-chlorophenol, benzyl alcohol p-chloro1-cresol, thymol, Phenethyl alcohol, 0-phenylphenol, Irgasan C113
565. Examples include halocarpane, hexachlorophene, chlorhexidine, ethyl alcohol, isopropyl alcohol, chlorobutanol, hexamine, acrinol, and the like.
抗炎症剤、創傷治癒剤としては、例えば、イクタモール
、ヒノキチオール、グリチルレチン酸及びその誘導体、
グリチルリチン酸、ビサボロール、アルミニウムクロル
ヒドロキシアラントイネート。Examples of anti-inflammatory agents and wound healing agents include ictamol, hinokitiol, glycyrrhetinic acid and its derivatives,
Glycyrrhizic acid, bisabolol, aluminum chlorohydroxyallantoinate.
塩酸グルコサミン、アラントイン及びその誘導体、ノノ
イルパニリールアミド、カロペプタイド、アズレン、イ
プシロンアミノカプロン酸、エスクリン、1−オキシエ
チル−4,5−ジフェニルイミダゾール、ビフィズス菌
抽出物,乳酸菌発酵液,牛脂盤エキス、人胎盤エキス、
牛牌臓抽出物,パン酵母抽出エキス、ロイヤルゼリー、
DNA−Na.DNA4. DNA. RNA,コラー
ゲン、ポリペブタイド、硫酸プロタミン等を挙げること
ができる。Glucosamine hydrochloride, allantoin and its derivatives, nonoyl panillylamide, calopeptide, azulene, epsilon aminocaproic acid, aesculin, 1-oxyethyl-4,5-diphenylimidazole, bifidobacterium extract, lactic acid bacteria fermentation liquid, beef blizzard extract, human placenta extract,
Beef viscera extract, baker's yeast extract, royal jelly,
DNA-Na. DNA4. DNA. Examples include RNA, collagen, polypeptide, protamine sulfate, and the like.
精油としては、例えば、ハツカ油,ジャスミン油、ショ
ウ脳油、ヒノキ油、トウヒ油,リュウ油。Examples of essential oils include peppermint oil, jasmine oil, ginger oil, cypress oil, spruce oil, and rhubarb oil.
テレピン油,ケイ皮油、ベルガモツト油、ミカン油,シ
ョウブ油,パイン油,ラベンダー油、ペイ油、クローブ
油、ヒバ油,バラ油,ユーカリ油。Turpentine oil, cinnamon bark oil, bergamot oil, tangerine oil, calamus oil, pine oil, lavender oil, Pei oil, clove oil, cypress oil, rose oil, eucalyptus oil.
レモン油、タイム油、ペパーミント油、ローズ油。Lemon oil, thyme oil, peppermint oil, rose oil.
セージ油、メントール、シネオール、オイゲノール、シ
トラール、シトロネラール、ボルネオール。Sage oil, menthol, cineole, eugenol, citral, citronellal, borneol.
リナロール、ゲラニオール、カンファー、チモール、ス
ピラントール、ピネン、リモネン、テルペン系化合物等
を挙げることができる。Examples include linalool, geraniol, camphor, thymol, spilanthol, pinene, limonene, and terpene compounds.
収れん剤としては、例えば、乳酸、酒゛石酸、コハク酸
、クエン酸、アジピン酸、ホウ酸,ウィッチハーゼル、
アラントイン、アラントインクロルヒドロキシアルミニ
ウム、アラントインジヒドロキシアルミニウム、カラミ
ン、酸化亜鉛、p−フェノールスルホン酸亜鉛、硫酸ア
ルミニウムカリウム、レゾルシン、塩化第二鉄、タンニ
ン酸等を挙げることができる。Examples of astringents include lactic acid, tartaric acid, succinic acid, citric acid, adipic acid, boric acid, Witschhasel,
Examples include allantoin, allantoin chlorhydroxyaluminum, allantoin dihydroxyaluminum, calamine, zinc oxide, zinc p-phenolsulfonate, potassium aluminum sulfate, resorcinol, ferric chloride, and tannic acid.
発汗防止防臭剤としては、例えば、塩化アルミニウム、
硫酸アルミニウム、クエン酸アルミニウム、酢酸アルミ
ニウム、塩基性塩化アルミニウム。Examples of antiperspirant deodorants include aluminum chloride,
Aluminum sulfate, aluminum citrate, aluminum acetate, basic aluminum chloride.
フェノールスルホン酸アルミニウム、β−ナフトールジ
スルホン酸アルミニウム、酢酸鉛、過ホウ酸ナトリウム
等が挙げられる。Examples include aluminum phenolsulfonate, aluminum β-naphthol disulfonate, lead acetate, and sodium perborate.
本発明のボディリンス組成物は、洗浄後の肌に適量を全
身に塗布し、シャワーなどにより軽くすすぐことにより
用いられ゛る。この組成物は、フェイシャルリンスとし
て使用しても、良好な使用感が得られ,特に問題は生じ
なかった.また、通常のクリーム、乳液等と同様に、す
すぎ流さないタイプの化粧料として使用することも可能
である。The body rinse composition of the present invention can be used by applying an appropriate amount to the entire body after washing and rinsing the body with a shower or the like. Even when this composition was used as a facial rinse, a good feeling was obtained and no particular problems occurred. In addition, it can also be used as a non-rinsing type cosmetic, similar to ordinary creams, emulsions, etc.
本発明のボディリンス組成物は、肌荒れしている部位、
肌がカサつきやすい部位、乾燥しやすい部位にエステル
油が吸着しやすいため、これらの部位にはしっとり感を
与え、反対に、油っぽく、べたつきやすい部分にはエス
テル油はあまり吸着しないため、過度のべたつきや油っ
ぽさを与えない.また、ポリシロキサンは肌質に関係な
く、はぼ一定量吸着するため、どんな肌質においてもポ
リシロキサンの特徴であるすべすべ感が得られ、かつ、
さっばりとした使用感をうることができる。The body rinse composition of the present invention can be applied to areas with rough skin,
Ester oil easily adsorbs to areas where the skin is prone to dryness and dryness, giving a moisturized feel to these areas, while on the other hand, ester oil does not adsorb much to areas that tend to be oily and sticky. Does not give excessive stickiness or oiliness. In addition, polysiloxane absorbs a certain amount regardless of skin type, so any skin type can get the smooth feeling that is characteristic of polysiloxane.
You can enjoy a light feeling of use.
前記作用により1本発明のボディリンス組成物では、肌
質1部位に関係なく、理想的な使用感を得ることのでき
る全身のボディケアが可能である。Due to the above-mentioned effects, the body rinse composition of the present invention allows whole-body body care that provides an ideal feeling of use, regardless of skin type or site.
また、本発明のボディリンス組成物は、風呂あがり後に
使用する通常のクリームや乳液等とは異なり、浴室内で
使用されるため、寒気に肌をさらさずに使用ができる等
使用法も簡単であり、さらに、油分等が全身に薄膜とな
り吸着するため、入浴後タオルで水気をふき取り易く、
体が冷えにくいという効果が得られる。しかも、べたつ
きや油性感が極めて少なく、肌をすべすべにする、肌を
しっとりさせる全身的なボディケア効果にすぐれ、また
軽くさっばりした使用感も得られる。また、べたつかず
、肌がすべすべしているため、下着やパジャマを着る際
に、からだに引っかからずスムーズに着ることができる
利点もある。In addition, the body rinse composition of the present invention is easy to use, as it is used in the bathroom, unlike ordinary creams and emulsions that are used after taking a bath, so it can be used without exposing the skin to cold air. In addition, oil and other substances form a thin film all over the body and are absorbed, making it easy to wipe off moisture with a towel after bathing.
This will help keep your body from getting cold. What's more, it has very little stickiness or oily feel, has excellent systemic body care effects that make the skin smooth and moisturized, and also provides a light and refreshing feeling. Additionally, since it is non-sticky and smooth on the skin, it has the advantage of being able to be worn smoothly when wearing underwear or pajamas without getting caught on the body.
さらに1本発明のボディリンス組成物は、すすぎ流すこ
とにより、皮膚上に乳化剤としての界面活性剤がほとん
ど残存しないため、界面活性剤によるべたつきや皮膚刺
激等の影響がほとんどなく、比較的皮膚刺激に対して敏
感な人に対しても安全に使用ができる。しかも、べたつ
きや油性感が極めて少なく、かつ油分等の有効成分が皮
膚に残り易いため、肌をすべすべにする、肌をしっとり
させる等のボディケア効果にすぐれ、また軽くさっばり
した使用感も得られることから、非常に優れた皮膚化粧
料である。したがって、現在のクリームや乳液等より安
全性の高い化粧料として顔や身体に使用するのに好適で
ある。また、本発明の組成物は、使用感が良好であるた
め、季節や使用部位にとられれず、良好な使用感が得ら
れることがら、これを毎日、全身に使用することにより
、前記した一般的なボディケア効果はもちろん、それと
同時に、肌荒れや、肌のカサつき、乾燥肌を解消すると
ともに、その予防にもなり得る。Furthermore, when the body rinse composition of the present invention is rinsed off, almost no surfactant as an emulsifier remains on the skin, so there is almost no influence of stickiness or skin irritation caused by the surfactant, and it is relatively irritating to the skin. It can be safely used even by people who are sensitive to it. In addition, it has extremely low stickiness and oily feel, and active ingredients such as oil easily remain on the skin, so it has excellent body care effects such as making the skin smooth and moisturized, and also provides a light and refreshing feeling. This makes it an excellent skin cosmetic. Therefore, it is suitable for use on the face and body as a cosmetic that is safer than current creams and emulsions. In addition, since the composition of the present invention has a good feeling when used, it does not depend on the season or the area where it is used, and provides a good feeling when used. Not only does it have a body care effect, but it also relieves and prevents rough skin, itchy skin, and dry skin.
次に本発明を実施例により、さらに詳細に説明する。 Next, the present invention will be explained in more detail with reference to Examples.
実施例1
ポリシロキサン(1000cs) 5
バルミチン酸イソプロピル 5P、O,E
、オレイルエーテル 1ソルビタンモ
ノステアレート 1カルボキシビニルポリ
マー 0.1グリセリン
5香料 0
.2プロピルパラベン 0.2メチ
ルパラベン 0.2精製水
バランス処方Iの本発明のボデ
ィリンス組成物を用いて性能を評価した。まず5通常の
肌の状態を調べるために入浴前に前腕内側部の皮膚のコ
ンダクタンス(μwho)を測定した6次に入浴洗浄後
前記ボディリンス組成物を約0.1g/9aJで塗布し
、軽くすすぎ流し、風乾後、フーリエ変換赤外分光光度
計(日本電子層:JIR−40X、全反射吸収スペクト
ル法)を用い、ポリシロキサン、パルミチン酸イソプロ
ピルの特性吸収を測定し、検量線よりそれらの吸着量を
算出した。尚、全反射吸収スペクトル法により直接皮膚
の油分量を測定するため、アタッチメントとしてスキン
アナライザー(スペクトラチック環、高屈折率媒質:Z
n5s)を使用した。Example 1 Polysiloxane (1000cs) 5
Isopropyl valmitate 5P, O, E
, oleyl ether 1 sorbitan monostearate 1 carboxyvinyl polymer 0.1 glycerin
5 fragrance 0
.. 2 Propylparaben 0.2 Methylparaben 0.2 Purified water
Performance was evaluated using the body rinse composition of the present invention in Balance Formula I. First, 5. To check the normal skin condition, the conductance (μwho) of the skin on the inner side of the forearm was measured before taking a bath. 6. After bathing and cleaning, apply the body rinse composition at about 0.1 g/9 aJ and lightly After rinsing and air drying, the characteristic absorption of polysiloxane and isopropyl palmitate was measured using a Fourier transform infrared spectrophotometer (JEOL: JIR-40X, total reflection absorption spectrometry), and their adsorption was determined from the calibration curve. The amount was calculated. In addition, in order to directly measure the oil content of the skin by total reflection absorption spectroscopy, a skin analyzer (spectral ring, high refractive index medium: Z) is used as an attachment.
n5s) was used.
検量線は、油分を種々の濃度となるようにエタノールま
たはn−ヘキサンに溶解し、マイクロシリンジで前腕内
側部に規定量塗布し、試料塗布部をスキンアナライザー
のZn5e部に当て、赤外線吸収スペクトルを得、皮膚
の特性吸収(アミドI結合=1645cm−” )と油
分の特性吸収の比により作成した。The calibration curve was prepared by dissolving oil in ethanol or n-hexane to various concentrations, applying a specified amount to the inner side of the forearm with a microsyringe, applying the sample application part to the Zn5e part of the skin analyzer, and measuring the infrared absorption spectrum. It was created based on the ratio of the characteristic absorption of the skin (amide I bond = 1645 cm-'') and the characteristic absorption of oil.
尚、皮膚がZn5eと接触している面積を4cm”と仮
定し、n=40の積算により吸収スペクトルを得た。It should be noted that the absorption spectrum was obtained by integrating n=40, assuming that the area where the skin was in contact with Zn5e was 4 cm''.
この方法により、使用前(通常時)の皮膚のコンダクタ
ンス(μwha)と使用後の油分の吸着量の関係につい
て30名による結果を第1図及び第2図に示す。Using this method, the results obtained by 30 people regarding the relationship between the skin conductance (μwha) before use (normal) and the amount of oil adsorption after use are shown in FIGS. 1 and 2.
尚、コンダクタンスは、高ければ高い程脂性肌であるこ
とを示し、低い程乾性肌であることを示す。In addition, the higher the conductance, the more oily the skin, and the lower the conductance, the more dry the skin.
第1図からは、コンダクタンスが変化してもポリシロキ
サン(1000cs)の吸着量に変化がないことから、
肌質に関係なく、ポリシロキサンはほぼ一定量吸着して
いることがわかる。したがって、このポリシロキサンは
、どのような肌質に対してもほぼ同様のすべすべ感、さ
っばり感を付与することが可能である。From Figure 1, it can be seen that even if the conductance changes, the adsorption amount of polysiloxane (1000 cs) does not change.
It can be seen that polysiloxane is adsorbed in an almost constant amount regardless of skin type. Therefore, this polysiloxane can impart almost the same smooth and light feeling to any skin type.
第2図からは、コンダクタンスの増加に伴ない、パルミ
チン酸イソプロピルの吸着量が低下していることがわか
る。また、保湿効果が高く、あまり油分(しっとり感)
を必要としない脂性肌の人においては吸着量が低いこと
が判る。From FIG. 2, it can be seen that as the conductance increases, the amount of isopropyl palmitate adsorbed decreases. In addition, it has a high moisturizing effect and does not contain much oil (moist feeling).
It can be seen that the amount of adsorption is low in people with oily skin who do not need it.
一方、コンダクタンスの低い、つまり、乾性肌の人に対
しては多量にパルミチン酸イソプロピルが吸着している
ことが判る。On the other hand, it can be seen that a large amount of isopropyl palmitate is adsorbed to people with low conductance, that is, dry skin.
実施例2
次に、乾性肌、普通肌、脂性肌の各々10名を集め、処
方■のボディリンス組成物についての使用感評価を行な
った。使用感は各々5段階評価で行ない、各項目毎に平
均点を算出した。尚、使用感の評価基準は、以下の通り
であり、その結果を表に示す。Example 2 Next, 10 people with dry skin, normal skin, and oily skin were gathered to evaluate the feeling of using the body rinse composition of prescription (1). The feeling of use was evaluated on a five-point scale, and the average score was calculated for each item. The evaluation criteria for the usability are as follows, and the results are shown in the table.
5:極めて良好
4:良 好
3:どちらとも言えない
2:やや不良
1:不良
表 脂質と使用感
表より1本発明組成物は、乾性肌、普通肌、脂性肌を問
わず、しっとり感、肌のすべすべ感、さっばり感、べた
つきのなさ、油性感のなさのすべての項目において良好
な使用感を示すことが確認できた。また乾性肌でもしっ
とり感が充分満足のいく評価が得られ、反対に、脂性肌
においては。5: Very good 4: Good 3: Neutral 2: Slightly poor 1: Poor From the lipid and feeling table, 1 The composition of the present invention provides a moist feeling, regardless of dry skin, normal skin, or oily skin. It was confirmed that the product had a good feeling of use in all categories including smooth skin, light feeling, no stickiness, and no oily feeling. The moisturizing effect was also rated as satisfactory even on dry skin, but on the contrary, on oily skin.
べたつき、油性感もなく、肌のすべすべ感が良好である
評価を得た。このように乾性肌、脂性肌といった脂質に
関係なく、両方とも満足のいく良好な結果が得られた理
由は、先の油分の吸着特性が関与しているものと考えら
れる。It was evaluated as having a good smooth feeling on the skin without any stickiness or oiliness. The reason why satisfactory results were obtained for both dry skin and oily skin, regardless of the type of lipid, is thought to be related to the aforementioned oil adsorption properties.
実施例3
処方■ボディリンス組成物
ミリスチン酸イソプロピル 5.0オク
タメチルシクロテトラシロキサン 10.0ステアリ
ン酸モノグリセリン 2.0POEグリセ
リルエーテル 2.0オリーブ油
2.0カルボキシビニルポ
リマー 0.11.3−ブチレングリコー
ル 5.0ジプロピレングリコール
2.0プロピルパラベン
0.1メチルパラベン
0.2香料
0.2グリチルリチン酸 0.
02精製水
バランス処方■のボディリンス
組成物の適量を入浴後の洗浄した濡れた肌に万遍なく塗
布し、軽くすすぎ流した後、タオルドライし、風乾後、
肌の感触を評価したところ、通常のクリーム、乳液等と
比較し、べたつきが非常に小さく、しかもさっばりとし
かつすべすべした感触を与えることが判った。Example 3 Prescription Body rinse composition Isopropyl myristate 5.0 Octamethylcyclotetrasiloxane 10.0 Monoglyceryl stearate 2.0 POE glyceryl ether 2.0 Olive oil
2.0 Carboxyvinyl polymer 0.11.3-Butylene glycol 5.0 Dipropylene glycol
2.0 Propylparaben
0.1 methylparaben
0.2 fragrance
0.2 Glycyrrhizic acid 0.
02 Purified water
After bathing, apply an appropriate amount of the body rinse composition of Balance Formula ■ evenly on your cleansed wet skin, rinse it off lightly, towel dry it, and then air dry it.
When the feel on the skin was evaluated, it was found that compared to ordinary creams, emulsions, etc., it has very little stickiness and gives a light and smooth feel.
またこのボディリンス組成物は肌質によって使用感に大
きな差がなく、との肌質においても良好な結果を示した
。In addition, this body rinse composition showed no significant difference in feeling when used depending on the skin type, and showed good results even for different skin types.
実施例4,5,6,7.8
実施例3のボディリンス組成物を下記処方■(実施例4
)、処方■(実施例5)、処方■(実施例6)、処方■
(実施例7)及び処方■(実施例8)のボディリンス組
成物に代え、その性能を評価したところ、各々実施例3
と同様に良好な結果が得られた。Examples 4, 5, 6, 7.8 The body rinse composition of Example 3 was formulated as follows (Example 4
), Prescription ■ (Example 5), Prescription ■ (Example 6), Prescription ■
(Example 7) and formulation (Example 8), the performance was evaluated.
Similar good results were obtained.
パルミチン酸イソプロピル 2.0ステ
アリン酸 4.0グリセリ
ン 5.0PEG6000モ
ノステアレート3.0グリセリルモノステアレート
1.5香料
0.1メチルパラベン
0.1ブチルパラベン 0.1
γ−オリザノール 0.1精
製水
バランスミリスチン酸オクチルデシル
3.0セチルアルコール
1.0ステアリン酸 3.0
トリエタノールアミン 0.5プロ
ピレングリコール 5.0ビーガム
0.2メチルパラベン
0.2ラノリンアルコール
0.5香料
0.1精製水
バランスパルミ
チン酸イソプロピル 10パラフインワツ
クス 1.0鯨ロウ
1.0グリセリルモノステアシー
ト 2.5P、0.Eソルビタンモノステア
レート 2.5ジプロピレングリコール
5.0カルボキシビニルポリマー
0.2メタルパラベン
0.2香料 0.
1ρ−アミノ安息香酸エチル 0.2オ
キシベンゾン o、iグアイ
アズレン 0.1トメントー
ル 0.2精製水
バ
ランスパルミチン酸イソプロピル 3.
0スクワラン 3.0ホ
ホバ油 2.OP、O
,Eオレイルエーテル 1.0ソルビ
タンモノステアレート 1.0ジプロピレ
ングリコール 5.Oカルボキシビニル
ポリマー 0.2ヒアルロン酸ナトリウム
0.05メチルパラベン
0・2プロピルパラベン
0.1精製水
バランスミリスチン酸イ
ソプロピル 20オクタメチルシクロテ
トラシロキサン 10グリセリン
5ソルビタンモノステアレート
2.OP、0.E!ラウリルエーテル
2.0カルボキシビニルポリマー 0
.2グリチルリチン酸ジカリウム 0.2
カミチレ抽出エキス 1.ODし一
セリン 0・l香料
0.2メチルパ
ラベン 0.1プロピルパラ
ベン 0.1エタノール
5精製水
バラン
ス実施例9
パルミチン酸イソプロピル 1.0セタノ
ール 1.0ミツロウ
1.0デカメチルシ
クロペンタシロキサン 2.0グリセリルモノス
テアレート 1.0P、O,Eソルビタン
モノラウレート1.。Isopropyl palmitate 2.0 Stearic acid 4.0 Glycerin 5.0 PEG6000 Monostearate 3.0 Glyceryl Monostearate
1.5 fragrance
0.1 methylparaben
0.1 Butylparaben 0.1
γ-oryzanol 0.1 purified water
Balanced Octyldecyl Myristate
3.0 cetyl alcohol
1.0 stearic acid 3.0
Triethanolamine 0.5 Propylene Glycol 5.0 Veegum
0.2 Methylparaben 0.2 Lanolin alcohol
0.5 fragrance
0.1 purified water
Balance Isopropyl Palmitate 10 Paraffin Wax 1.0 Whale Wax
1.0 Glyceryl monostear sheet 2.5P, 0. E-sorbitan monostearate 2.5 dipropylene glycol
5.0 carboxyvinyl polymer
0.2 metal paraben
0.2 Fragrance 0.
1 ρ-Ethyl aminobenzoate 0.2 Oxybenzone o, i Guaiazulene 0.1 Tomenthol 0.2 Purified water
Balanced Isopropyl Palmitate 3.
0 squalane 3.0 jojoba oil 2. OP, O
, E oleyl ether 1.0 sorbitan monostearate 1.0 dipropylene glycol 5. O carboxyvinyl polymer 0.2 Sodium hyaluronate 0.05 Methyl paraben
0.2 propylparaben
0.1 purified water
Balance Isopropyl myristate 20 Octamethylcyclotetrasiloxane 10 Glycerin
5 Sorbitan monostearate
2. OP, 0. E! lauryl ether
2.0 carboxyvinyl polymer 0
.. 2 Dipotassium glycyrrhizinate 0.2
Camichile extract 1. OD Serine 0.1 Fragrance 0.2 Methylparaben 0.1 Propylparaben 0.1 Ethanol
5 Purified water
Balance Example 9 Isopropyl palmitate 1.0 Cetanol 1.0 Beeswax 1.0 Decamethylcyclopentasiloxane 2.0 Glyceryl Monostearate 1.0 P, O, E Sorbitan Monolaurate 1. .
アスコルビン酸リン酸エステルマグネシウム0.5
γ−オリザノール 0.2香
料 0.05精製水
バランス処方■のボディリンス組成物をフェイ
シャルリンス剤として洗顔後の濡れた顔に適量塗布し、
軽くすすぎ流した後タオルドライし、風乾後、肌の感触
を評価したところ、通常の栄養クリーム、乳液等と比較
し、べたつきが小さく、シかもさっばりとしすべすべし
た感触を与えることが判った。またこのものは肌質によ
って使用感に大きな差はなく、どの肌質においても良好
な結果が示した。Magnesium ascorbic acid phosphate 0.5 γ-oryzanol 0.2 Fragrance 0.05 Purified water
Apply an appropriate amount of the balance prescription body rinse composition as a facial rinse to your wet face after washing.
After rinsing it off, towel drying it, and air-drying it, we evaluated the feel of the skin and found that it was less sticky and gave a light and smooth feel compared to regular nutritional creams and emulsions. Furthermore, there was no significant difference in the feeling of use depending on the skin type, and good results were obtained for all skin types.
実施例10
実施例9のボディリンス組成物を下記処方■の組成物に
代え、フェイシャルリンス剤としての性能を評価したと
ころ実施例9と同様に良好な結果が得られた。Example 10 The body rinse composition of Example 9 was replaced with a composition of the following formulation (2) and its performance as a facial rinse agent was evaluated. As in Example 9, good results were obtained.
メチルフェニルポリシロキサン 2.0ミリ
スチン酸イソプロピル 2.0オクタメ
チルシクロテトラシロキサン 2.0セタノール
1.0アラントイン
0.1ソルビタントリコラア
レート 1.0P、O,Eラウリルエーテ
ル 0・8カルボキシビニルポリマー
0.2グリセリン
5.0香料
O,OS精製水
バランス実施例11
ミリスチン酸イソプロピル 3.0セチル
アルコール 2.0ステアリン酸
5.0グリセリルモノス
テアレート 3.0グリセリン
5・0カルボキシビニルポリマー
0.2トリエタノールアミン
1.5メチルパラベン
0.2プロピルパラベン 0.
1酢酸dトα−トコフェロール 0.2
精製水
バランス処方Xのボディリンス組成物を
ハンドリンス剤として手洗い後の濡れた手に適量塗布し
、軽くすすぎ流した後、タオルドライし、風乾後、肌の
感触を評価したところ1通常のハンドクリームと比較し
て、べたつきが非常に小さく、さっばりとし。Methylphenylpolysiloxane 2.0 Isopropyl myristate 2.0 Octamethylcyclotetrasiloxane 2.0 Cetanol
1.0 Allantoin
0.1 Sorbitan tricolaate 1.0 P, O, E lauryl ether 0.8 carboxyvinyl polymer 0.2 Glycerin
5.0 fragrance
O,OS purified water
Balance Example 11 Isopropyl myristate 3.0 Cetyl alcohol 2.0 Stearic acid 5.0 Glyceryl monostearate 3.0 Glycerin
5.0 carboxyvinyl polymer
0.2 triethanolamine
1.5 methylparaben
0.2 Propylparaben 0.
d-α-tocopherol acetate 0.2
purified water
After applying an appropriate amount of the body rinse composition of Balance Prescription In comparison, it is much less sticky and feels light.
かつすべすべした感触を与えることが判った。また、こ
のものは手の荒れの程度による差はほとんどなくとの肌
質においても良好な結果を示した。It was found that it gave a smooth and smooth feel. This product also showed good results in terms of skin quality, with almost no difference depending on the degree of roughness of the hands.
更に、手荒れのひどい人に対して1週間の連続使用評価
を行なった結果1手荒れの改善効果が顕著に認められた
。Furthermore, when we evaluated the continuous use of the product for one week on people with severe chapped hands, we found that it was significantly effective in improving chapped hands.
実施例12
実施例11のボディリンス組成物を下記処方亘に代え、
ハンドリンス剤としての性能を評価したところ実施例1
1と同様に良好な結果が得られた。Example 12 The body rinse composition of Example 11 was replaced with the following formulation,
When the performance as a hand rinse agent was evaluated, Example 1
Similar to 1, good results were obtained.
ポリシロキサン(1000cs)
7.0パルミチン酸イソプロピル 3.
0ミンク油 3.0
デカメチルシクロペンタシロキサン 5.0グリ
セリルモノステアレート 2.0ジプロピ
レングリコール 5.0メチルパラベン
0,2プロピルパラベン
0.1アロエ抽出末
1.0カルボキシビニルポリマー
0.2精製水
バランスPolysiloxane (1000cs)
7.0 Isopropyl palmitate 3.
0 mink oil 3.0
Decamethylcyclopentasiloxane 5.0 Glyceryl Monostearate 2.0 Dipropylene Glycol 5.0 Methylparaben 0,2 Propylparaben
0.1 aloe extract powder
1.0 carboxyvinyl polymer
0.2 Purified water
balance
第1図及び第2図は、本発明のボディリンス組成物を皮
膚に塗布し、軽くすすぎ流し、風乾した後に残る油分吸
着量と皮膚コンダクタンスとの関係を示すグラフである
。第1図はポリシロキサン吸着量と皮膚コンダクタンス
との関係、第2図はパルミチン酸イソプロピルと皮膚コ
ンダクタンスとの関係を示す。FIGS. 1 and 2 are graphs showing the relationship between the amount of oil adsorption remaining after the body rinse composition of the present invention is applied to the skin, lightly rinsed off, and air-dried, and the skin conductance. FIG. 1 shows the relationship between the amount of polysiloxane adsorption and skin conductance, and FIG. 2 shows the relationship between isopropyl palmitate and skin conductance.
Claims (2)
る乳化組成物であって、不揮発性ポリシロキサンを1〜
40重量%含有し、かつ、エステル油を1〜40重量%
含有することを特徴とする入浴後の肌に塗布し、軽くす
すぎ流して使用するボディリンス組成物。(1) An emulsified composition having an oil content of 2 to 50% by weight based on the entire composition, and containing 1 to 50% of nonvolatile polysiloxane.
Contains 40% by weight and 1 to 40% by weight of ester oil
A body rinse composition that is applied to the skin after bathing and is used by gently rinsing it off.
のエステル油の中から選ばれる少なくとも1種である請
求項(1)の組成物。(2) The composition according to claim (1), wherein the ester oil is at least one selected from ester oils that are liquid or pasty at room temperature.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10694388A JPH01279816A (en) | 1988-04-28 | 1988-04-28 | Body rinse composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10694388A JPH01279816A (en) | 1988-04-28 | 1988-04-28 | Body rinse composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01279816A true JPH01279816A (en) | 1989-11-10 |
Family
ID=14446459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10694388A Pending JPH01279816A (en) | 1988-04-28 | 1988-04-28 | Body rinse composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01279816A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007070297A (en) * | 2005-09-08 | 2007-03-22 | Shiseido Co Ltd | Method for pretreatment of skin care and rinse composition for the skin |
JP2012139311A (en) * | 2010-12-28 | 2012-07-26 | Kao Corp | Method for designing cosmetic material containing warming agent |
JP2018108955A (en) * | 2016-12-28 | 2018-07-12 | 小林製薬株式会社 | Aqueous formulation |
JP2019006736A (en) * | 2017-06-28 | 2019-01-17 | 小林製薬株式会社 | Pharmaceutical composition |
JP2019006738A (en) * | 2017-06-28 | 2019-01-17 | 小林製薬株式会社 | Pharmaceutical composition |
JP2019006737A (en) * | 2017-06-28 | 2019-01-17 | 小林製薬株式会社 | Pharmaceutical composition |
-
1988
- 1988-04-28 JP JP10694388A patent/JPH01279816A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007070297A (en) * | 2005-09-08 | 2007-03-22 | Shiseido Co Ltd | Method for pretreatment of skin care and rinse composition for the skin |
JP2012139311A (en) * | 2010-12-28 | 2012-07-26 | Kao Corp | Method for designing cosmetic material containing warming agent |
JP2018108955A (en) * | 2016-12-28 | 2018-07-12 | 小林製薬株式会社 | Aqueous formulation |
JP2019006736A (en) * | 2017-06-28 | 2019-01-17 | 小林製薬株式会社 | Pharmaceutical composition |
JP2019006738A (en) * | 2017-06-28 | 2019-01-17 | 小林製薬株式会社 | Pharmaceutical composition |
JP2019006737A (en) * | 2017-06-28 | 2019-01-17 | 小林製薬株式会社 | Pharmaceutical composition |
JP2021152081A (en) * | 2017-06-28 | 2021-09-30 | 小林製薬株式会社 | Pharmaceutical composition |
JP2021152080A (en) * | 2017-06-28 | 2021-09-30 | 小林製薬株式会社 | Pharmaceutical composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4014995A (en) | Cosmetics containing finely divided oat flour | |
FR2561102A1 (en) | TOPICAL RELEASE SYSTEM AND SKIN TREATMENT COMPOSITIONS USING SUCH A SYSTEM | |
JP4546973B2 (en) | Water-resistant fragrance cosmetic composition | |
JP3923226B2 (en) | Topical skin preparation | |
JP5550863B2 (en) | Cosmetics | |
JP2002275020A (en) | Oil agent, and cosmetic and external agent containing the same | |
JPH06279227A (en) | Dermatic external preparation and cosmetic | |
JPS62292710A (en) | Skin cosmetic | |
JPH01279816A (en) | Body rinse composition | |
JPH09315937A (en) | Gelled composition, emulsion composition and preparation for external use for skin | |
JP2021088523A (en) | Skin cosmetics | |
JPS61282310A (en) | Hair cosmetic | |
US20060148907A1 (en) | Topical antinflammatory preparations of y-terpinene | |
JP2847190B2 (en) | Body rinse composition | |
JP4310008B2 (en) | Cosmetics | |
JP2626776B2 (en) | Body rinse composition | |
JPH0892062A (en) | External preparation | |
JP2000344697A (en) | Long-chain branched alcohol and cosmetic and external preparation produced by using the alcohol | |
JPH04134012A (en) | Sebum secretion promoter | |
JP5296500B2 (en) | Hair conditioning composition | |
JPH0338511A (en) | External preparation | |
JPH0469319A (en) | Hair-treating agent | |
JPH02202810A (en) | Body rinse composition for dry skin | |
JP2008179585A (en) | Skin detergent composition | |
JP2003081806A (en) | Skin care preparation |